A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | COVID-19 VACCINE POLICIES | |||||||||||||||||||||||||||
2 | ||||||||||||||||||||||||||||
3 | NO. | Agency | Policy Type | Policy Number | Policy Title | Date Released | Link | |||||||||||||||||||||
4 | 1 | Senate and House | Republic Act | RA 11525 | An Act Establishing the Coronavirus Disease 2019 (COVID-19) Vaccination Program Expediting the Vaccine Procurement and Adminsitration Process, Providing Funds Therefore, and For Other Purposes | February 26, 2021 | https://drive.google.com/file/d/1rSI7aSyficHxU8D4SqOZj2_NLK9XLhRX/view?usp=sharing | - | ||||||||||||||||||||
5 | 2 | National Task Force Against COVID-19 - Department of Health | Joint Adminsitrative Order | JAO 2021-0001 | Implementing Rules and Regulations of Republic Act No. 11525 known as "An Act Establishing the Coronavirus Disease 2019 (COVID-19) Vaccination Program Expediting the Vaccine Procurement and Adminsitration Process, Providing Funds Therefor, and For Other Purposes." | March 26, 2021 | https://drive.google.com/file/d/1VeRRTejRqELx0hs6DHefku_qnwZH7tQn/view?usp=sharing | |||||||||||||||||||||
6 | 3 | National Task Force Against COVID-19 | NTF Memorandum Circular | MC 05 s. 2021 | Adaptation and Implementation of the Philippine National Deployment and Vaccination Plan for COVID-19 Vaccines | January 26, 2021 | https://drive.google.com/file/d/1zt5k7C8s9aVbwyzNIzMuVjRCTBBBNWnt/view?usp=sharing | - | ||||||||||||||||||||
7 | 4 | The Philippine National Deployment and Vaccination Plan for COVID-19 Vaccines | January 26, 2021 | https://drive.google.com/file/d/1kLE5IVNXs27957lRAPyfiIHGQ7cPsvsa/view?usp=sharing | ||||||||||||||||||||||||
8 | 5 | Department of Health | Administrative Order | AO 2021-005 | National Strategic Policy Framework for COVD-19 Vaccine Deployment and Immunization | January 12, 2021 | https://drive.google.com/file/d/11TCOlFpCG11SM8cGTFLPBRAtDPttgWlY/view?usp=sharing | - | ||||||||||||||||||||
9 | 6 | Department Circular | DC 2021-0009 | Department of Health's Strategic Plan for COVID-19 Vaccination (2021-2023) and National Strategic Policy Framework for COVID-19 Vaccine Deployment and Immunization | January 14, 2021 | https://drive.google.com/file/d/1OLWaGsWzUuxYbOrnY7U39CYvxR3kRhum/view?usp=sharing | - | |||||||||||||||||||||
10 | 7 | Department Circular | DC 2021-0101 | Clarification on Provisions of Department Memorandum 2021-0099 entitled the "Interim Omnibus Guidelines for the Implementation of the National Vaccine Deployment Plan for COVID-19 | March 11, 2021 | https://drive.google.com/file/d/1btqapjb_OpQFYVF4r1uq1U7zNMDfEwe_/view?usp=sharing | - | |||||||||||||||||||||
11 | 8 | Department Memorandum | DM 2021-0007 | Advisory on the VigiFlow Training on January 12, 2021 | January 06, 2021 | https://drive.google.com/file/d/1BBnQt-a02ZjPmRUhLS0T5VAUYkhko4gl/view?usp=sharing | - | |||||||||||||||||||||
12 | 9 | Department Memorandum | DM 2021-0047 | Interim Guidelines on Masterlisting for the COVID-19 Electronic Immunization Registry (CEIR) - Phase 1 | January 11, 2021 | https://drive.google.com/file/d/18lTKZOZMIxpfvbF3bfq_aJy56uMu0hU3/view?usp=sharing | - | |||||||||||||||||||||
13 | 10 | Department Memorandum | DM 2021-0029 | Online Trainings for the Deployment of COVID-19 Vaccination | January 15, 2021 | https://drive.google.com/file/d/1A2iMbFcaJlH_rbk5hNC5CMpur0ng7ARF/view?usp=sharing | - | |||||||||||||||||||||
14 | 11 | Department Memorandum | DM 2021-0031 | Interim Guidelines on the Management of Health Care Wastes Generated from COVID-19 Vaccination | January 18, 2021 | https://drive.google.com/file/d/1igE7tDDGh-IBInBhcvX8Aj2HeXNesZjh/view?usp=sharing | - | |||||||||||||||||||||
15 | 12 | Department Memorandum | DM 2021-0053 | Interim Guidelines on the Shipment and Acceptance of the COVID-19 Vaccines and Ancillary Immunization Commodities | January 28, 2021 | https://drive.google.com/file/d/1QYgaWJuRkXco09T47mpK3mvcG7zQTPRJ/view?usp=sharing | - | |||||||||||||||||||||
16 | 13 | Department Memorandum | DM 2021-0066 | Updating of the National Health Facility Registry (NHFR) for the COVID-19 Electronic Immunization Registry (CEIR) | February 1, 2021 | https://drive.google.com/file/d/1vbcchZUtFGk1c-Rb1UlGvzQfu2ANEYVi/view?usp=sharing | - | |||||||||||||||||||||
17 | 14 | Department Memorandum | DM 2021-0090 | Dissemination of the Results of COVID-19 Vaccine Sectoral Survey Round 1 to DOH Central Office | February 11, 2021 | https://drive.google.com/file/d/1UaGd1uiJ_9trmauvUmzzmuyC4ouCzD9g/view?usp=sharing | - | |||||||||||||||||||||
18 | 15 | Department Memorandum | DM 2021-0099 | Interim Omnibus Guidelines for the Implementation of the National Vaccine Deployment Plan for COVID-19 | February 23, 2021 | https://drive.google.com/file/d/1eGOQnb_GFVaAa8kvwyCxqpGAMvooOiK5/view?usp=sharing | - | |||||||||||||||||||||
19 | 16 | Department Memorandum | DM 2021-0114 | Guidelines on the Management and Administration of the Initial 600,000 Donated SARS COV-2 Vaccine (Vero Cell) Inactivated CoronaVac (Sinovac) Doses | February 26, 2021 | https://drive.google.com/file/d/1Sqg6Ye4mMXGxyu3BOgjF7sFJEvMPncnO/view?usp=sharing | - | |||||||||||||||||||||
20 | 17 | Department Memorandum | DM 2021-0116 | Interim Guidelines on the Identification and Utilization of COVID-19 Vaccination Sites | February 26, 2021 | https://drive.google.com/file/d/1OPjvuk7cmn-RvaMwEZJb24YaIDYc0SJR/view?usp=sharing | - | |||||||||||||||||||||
21 | 18 | Department Memorandum | DM 2021-0123 | Interim Guidelines for the Management and Adminsitration of AstraZeneca (ChAdOx1-S [recombinant]) COVID-19 Vaccine | March 4, 2021 | https://drive.google.com/file/d/1MGzHPQgP7F9segaLCVuBPBLxn2NARTCp/view?usp=sharing | - | |||||||||||||||||||||
22 | 19 | Department Memorandum | DM 2021-0137 | Interim Operational Guidelines on the Utilization of the Distribution AstraZeneca Vaccines from COVAX Facility | March 18, 2021 | https://drive.google.com/file/d/1MxM--4QY2gmd2NtHELWRmQ5FbqsUeduA/view?usp=sharing | - | |||||||||||||||||||||
23 | 20 | Department Memorandum | DM 2021-0153 | Submission of Daily Distribution Reports of COVID-19 Vaccines | March 19, 2021 | https://drive.google.com/file/d/1d3X6Pf_sq7j9Ez5N-ZyCs1ycMRanxDwc/view?usp=sharing | - | |||||||||||||||||||||
24 | 21 | Department Memorandum | DM 2021-0152 | Submission of the Revised Vaccine Arrival Report | March 21, 2021 | https://drive.google.com/file/d/1zXQ5V2FlDlr52bdbTPHQ8RSd2Bms4Wxs/view?usp=sharing | - | |||||||||||||||||||||
25 | 22 | Department Memorandum | DM 2021-0154 | Reiteration on the Acceptance of the COVID-19 Vaccines in the Cold Storage Facilities | March 23, 2021 | https://drive.google.com/file/d/1yb2CY4Mn-cqLJdd9Nux3iCSCUnI1ze7-/view?usp=sharing | - | |||||||||||||||||||||
26 | 23 | Department Memorandum | DM 2021-0157 | Implementing Guidelines for Priority Group A3 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines | March 30, 2021 | https://drive.google.com/file/d/10y-8jZ3qBa9gVjJuDieNNXQLnhZY0VHx/view?usp=sharing | - | |||||||||||||||||||||
27 | 24 | Department Memorandum | DM 2021-0175 | Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines and Additional Guidelines for Sinovac Vaccine Implementation | April 8, 2021 | https://drive.google.com/file/d/1iLqs9mo6QcVAGF_nTQ6x1f_dTZI_SUnc/view?usp=sharing | - | |||||||||||||||||||||
28 | 25 | Department Memorandum | DM 2021-0190 | Guidelines for the Management and Adminsitration of Gamaleya (Sputnik V Gam-COVID-Vac) COVID-19 Vaccine | April 12, 2021 | https://drive.google.com/file/d/1t2R119qqyMqelHxHHSrbBXCLO_s5e2al/view?usp=sharing | - | |||||||||||||||||||||
29 | 26 | Department Memorandum | DM 2021 - 0218 | Further Clarification on the National Vaccinatioin Deployment Plan on Health Screening and Management of Adverse Events Following Immunization | May 4, 2021 | https://drive.google.com/file/d/1zajFYliCOcTzVMJvCdS2zUHKtORIFmR8/view?usp=sharing | ||||||||||||||||||||||
30 | 27 | Department Memorandum | DM 2021-0225 | Guidelines on the Management and Administration of the Pfizer-BioNTech COVID-19 (BNT162b2) Vaccine | May 11, 2021 | https://drive.google.com/file/d/1QbS3jYcady8u1NbxlunATESu4-O-LJjy/view?usp=sharing | ||||||||||||||||||||||
31 | 28 | Department Memorandum | DM 2021-0259 | implementing Guidelines for Priority Group A4, A5 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines | May 31, 2021 | https://drive.google.com/file/d/1FFR_4xxAWDXnO2EHXx3z2VfKDnJvQQM6/view?usp=sharing | ||||||||||||||||||||||
32 | 29 | Department Memorandum | DM 2021-0260 | Engagement of Health Professionals and the Graduates of Health Sciences Education Courses as Members of the COVID-19 Vaccination Teams | May 18, 2021 | https://drive.google.com/file/d/1v5llsdbdlIk04Eb6KTe5se90qBWUHtNx/view?usp=sharing | ||||||||||||||||||||||
33 | 30 | PhilHealth | PhilHealth Circular | PhilHealth Circular No. 2021-0007 | Implementing Guidelines on the Coverage of COVID-19 Vaccine Injury due to Serious Adverse Effects (SAEs) Following Immunization Resulting in Hospitaliztion, Permanent Disability, or Death under the COVID-19 National Vaccine Indemnity Fund (The COVID-19 Vaccine Injury Compensation Package) | May 17, 2021 | https://drive.google.com/file/d/1EjeraEIV566l-VMt1EyjB31lb5a-TB8k/view?usp=sharing | |||||||||||||||||||||
34 | 31 | Department of Health | Department Memorandum | DM 2021-0286 | Interim Operational Guidelines for the Implementation of Tutok A2: The Deployment of Vaccination Operations Optimization Strategies to Increase Vaccination Coverage among Priority Group A2: Senior Citizens | 23 June 2021 | https://drive.google.com/file/d/1S-5fvXlM34GAxh20HZ9YkDPbbI1d8d-3/view?usp=sharing | |||||||||||||||||||||
35 | 32 | Department of Health | Department Memorandum | DM 2021-0287 | Guidelines for the Management and Administration of COVID-19 mRNA Vaccine (Nucleoside Modified) Moderna COVID-19 Vaccine | 18 June 2021 | https://drive.google.com/file/d/1pKMeJvb5S3ZSFuhRPh64z42VwabZCIrD/view?usp=sharing | |||||||||||||||||||||
36 | 33 | DOH-NTF-FDA-DFA | Joint Memorandum Circular | JMC 2021-0001 | Guidelines for the Implementation of a COVID-19 Vaccination Program for Diplomatic Missions and Foreign Nationals | June 11 2021 | https://drive.google.com/file/d/1w94QsSgl7uEpt9ZpjY28fh956SCOgCuG/view?usp=sharing | |||||||||||||||||||||
37 | 34 | Department of Health | Department Memorandum | DM 2021-0315 | Guidelines for the Management and Administration of COVID-19 Vaccine (Ad26.COV2-S [recombinant]) ("Janssen COVID-19 Vaccine") | https://drive.google.com/file/d/1X6BQSpQxbalMosAUNuAWhun91UqloClP/view?usp=sharing | ||||||||||||||||||||||
38 | 35 | Department of Health | Department Memorandum | DM 2021-0354 | Interim Operational Guidelines on the On-Time Delivery of Pfizer-BioNTech COVID-19 Vaccines | 20 July 2021 | https://drive.google.com/file/d/1MVuYeikOswJJvqVR83iD11DvUChd8Gn4/view?usp=sharing | |||||||||||||||||||||
39 | 36 | Department of Health | Department Memorandum | DM 2021-0365 | Guidelines for the Management and Administration of the Donated COVID-19 Vaccine (Vero Cell), Inactivated Hayat-Vax Sinopharm | 11 August 2021 | https://drive.google.com/file/d/1YOM3WcmZwOAH4lu-u4UYWcii98ok9nVC/view?usp=sharing | |||||||||||||||||||||
40 | 37 | Department of Health | Department Memorandum | DM 2021-0406 | Further Clarification on the Priority Population Groups Specified in the Department Memorandum No. 2021-0099 | September 13, 2021 | https://drive.google.com/file/d/1zzapq_jA0soDe0WO-qekrJZDPOVshdkJ/view?usp=sharing | |||||||||||||||||||||
41 | 38 | Department of Health | Department Circular | DC 2021-0439 | Operational Guidelines on the Reverse Logistics of COVID-19 Vaccines | September 15, 2021 | https://drive.google.com/file/d/13GEu-KGpvAK_Qickzc4A_-WxyWkuILl5/view?usp=sharing | |||||||||||||||||||||
42 | 39 | Department of Health | Department Circular | DC 2021-0449 | Interim Operational Guidelines on the Rollout of the National COVID-19 Vaccine Deployment and Vaccination Program to the Rest of the Adult Population | September 30, 2021 | https://drive.google.com/file/d/1M09R5mXiG3JUINsJCe-Gv5kwmQBlFvjn/view?usp=sharing | |||||||||||||||||||||
43 | 40 | Department of Health and National Task Force against COVID-19 | Joint Memorandum Circular | JMC 2021-0002 | Operational Guidelines for the Donation and Subsequent Reallocation of Privately-procured COVID-19 Vaccine Doses to the National Government, Local Government Units (LGUs), and other Private Sector Entities | October 5, 2021 | https://drive.google.com/file/d/1uJCEYM7w736c0Zy786S6H-brdzrn8Jwk/view?usp=sharing | |||||||||||||||||||||
44 | 41 | Department of Health | Department Circular | DC 2021-0464 | Interim Operational Guidelines on the COVID-19 Vaccination of the Pediatric Population Ages 12-17 Years Old with Comorbidities | October 14, 2021 | https://drive.google.com/file/d/1QP8uvKX4TM56ud_Owr8SQrVhugSy60nh/view?usp=sharing | |||||||||||||||||||||
45 | 42 | Department of Health | Department Circular | DC 2021-0464-A | Amendment to Department Circular 2021-0464 entitled "Interim Operational Guidelines on the COVID-19 Vaccination of the Pediatric Population Ages 12-17 Years Old with Comorbidities | October 25, 2021 | https://drive.google.com/file/d/1gW4nSrMI9Zr3Ko8nH8YDESNJfOVSBS8F/view?usp=sharing | |||||||||||||||||||||
46 | 43 | Department of Health | Department Circular | DC 2021-0483 | Interim Operational Guidelines on the COVID-19 Vaccination of the Rest of the Pediatric Population Ages 12-17 Years Old | October 28, 2021 | https://drive.google.com/file/d/1LATX_ZfNTcAqp7CG9qqcRkba8YmfSZKC/view?usp=sharing | |||||||||||||||||||||
47 | 44 | Department of Health and Commission on Higher Education | Joint Memorandum Circular | JMC 2021-0002 | Interim Guidelines on the Voluntary Participation of Postgraduate/Undergraduate Interns, Clinical Clerks, and Fourth Year Nursing Students in the COVID-19 Vaccine | October 12, 2021 | https://drive.google.com/file/d/1tuDBh05SqQaqzHNk9r9UI2TIOfJzq1Oc/view?usp=sharing | |||||||||||||||||||||
48 | 45 | DOH | Department Circular | DOH DC - 2021-0525 | Reiteration of the Interim Operational Guidelines on the Administration of COVID-19 Vaccine Booster Doses to Priority Group A1: Essential HWorkers in Frontline Health Services (A1.1 to A1.7) | November 16, 2021 | https://drive.google.com/file/d/1a0DEEyg8YnKbCVvntsBsEn_-r8UE2QwM/view?usp=sharing | |||||||||||||||||||||
49 | 46 | DOH | Department Memorandum | DOH DM 2021-0484 | Interim Operational Guidelines on the Administration of COVID-18 Vaccine Booster Doses to Priority Group A1: Essential Workers in Frontline Health Services (A1.1 to A1.7) | November 16, 2021 | https://drive.google.com/file/d/16lj2pmWGHRAZj6P4BLR39r23gzCsoMLW/view?usp=sharing | |||||||||||||||||||||
50 | 47 | DOH | Department Memorandum | DOH DM 2021-0492 | Interim Guidelines on the Administration and Management of COVID-19 Vaccine Booster/Additional Doses to Priority Group A2: Senior Citizens ages 60 years old and above and Priority Group A3: Adults with Comorbidities | November 19, 2021 | https://drive.google.com/file/d/1V0vVSecJtZy_FIZt4T4ICmK213qRjNyc/view?usp=sharing | |||||||||||||||||||||
51 | ||||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||||
100 |